Free Trial
NASDAQ:IBB

iShares Biotechnology ETF (IBB) Price, Holdings, & News

iShares Biotechnology ETF logo
$124.24 +2.33 (+1.91%)
Closing price 04:00 PM Eastern
Extended Trading
$123.94 -0.30 (-0.24%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About iShares Biotechnology ETF (NASDAQ:IBB)

Key Stats

Today's Range
$121.61
$124.26
50-Day Range
$112.02
$132.97
52-Week Range
$107.43
$150.57
Volume
2.13 million shs
Average Volume
1.40 million shs
Market Capitalization
$5.44 billion
Assets Under Management
$5.13 billion
Dividend Yield
0.31%
Net Expense Ratio
0.45%
Aggregate Rating
Moderate Buy

ETF Overview

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

iShares Biotechnology ETF Expenses

TypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.45%0.57%0.57%0.54%0.53%
Other Expenses0.00%0.30%0.48%0.42%0.51%
Total Expense0.45%0.70%0.72%0.68%0.71%
Fee Waiver0.00%-0.45%-0.49%-0.29%-0.54%
Net Expense0.45%0.61%0.63%0.62%0.60%
Receive IBB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

IBB ETF News Headlines

This document could hand you a shot at $915 every single weekend!
Something fascinating happens in the options market when most traders aren't paying attention… While everyone else collects standard daily premiums Monday through Friday... There's a special opportunity to target TRIPLE premiums just for holding positions over the weekend. Think about that... Most traders get one day's worth of premium for their trades. But by entering right before the weekend, when everything works out, you could collect THREE days worth - even though markets are closed for two of them. Thanks to a special discovery by a Wall Street legend who helped manage a $1.7 trillion firm – regular folks like you can now target extra cash from the markets on weekends… Just like he showed his small group of traders on December 20th with KO... A quick 2-minute setup Friday afternoon… Head out for the weekend... Monday morning? An extra $1,111 sitting in the account (with a $5k starting stake).
See More Headlines

IBB ETF - Frequently Asked Questions

iShares Biotechnology ETF's stock was trading at $132.21 on January 1st, 2025. Since then, IBB stock has decreased by 6.0% and is now trading at $124.24.
View the best growth stocks for 2025 here
.

Shares of iShares Biotechnology ETF split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly created shares were distributed to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

Top institutional investors of iShares Biotechnology ETF include Citigroup Inc. (7.33%), BNP Paribas Financial Markets (2.09%), Royal Bank of Canada (1.75%) and Commerce Bank (1.37%).

Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Biotechnology ETF investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Fund Details

Issuer
iShares
Fund Name
iShares Biotechnology ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:IBB
Inception Date
2/5/2001
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE Biotechnology Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
263

Fund Statistics

Assets Under Management
$5.13 billion
Average Daily Volume
$2.01 million
Discount/Premium
-0.01%

Administrator, Advisor and Custodian

Administrator
J.P. Morgan Chase Bank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
JPMorgan Chase Bank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
J.P. Morgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Latour Trading

Options

Optionable
Optionable
Options Volume
1,177
Put Options
539
Call Options
638
Short Interest
12,860,000 shs

Miscellaneous

Beta
0.84
Creation Unit
50,000
Creation Fee
$614.00
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Top 10 IBB Holdings

IBB Sector Exposure

IBB Industry Exposure


This page (NASDAQ:IBB) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners